Sanders Criticizes Novo Nordisk Pricing
This is a U.S. news story, published by NBC News, that relates primarily to Bernie Sanders news.
U.S. news
For more U.S. news, you can click here:
more U.S. newsBernie Sanders news
For more Bernie Sanders news, you can click here:
more Bernie Sanders newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsNBC News news
For more news from NBC News, you can click here:
more news from NBC NewsAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
drugmaker Novo Nordisk. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Novo Nordisk news, generic drugmakers news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
blockbuster diabetes drug OzempicNBC News
•Bernie Sanders says Ozempic can be produced for less than $100 a month
83% Informative
Sen. Bernie Sanders says generic drug companies say they can sell Ozempic for less than $100 a month.
Novo Nordisk CEO Lars Fruergaard Jorgensen is testifying before the Senate Health, Education , Labor and Pensions Committee next week .
Jorgenson will testify over the pricing of Ozempin in the U.S. , as well as that of Wegovy .
VR Score
84
Informative language
84
Neutral language
75
Article tone
formal
Language
English
Language complexity
55
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
2
Affiliate links
no affiliate links